Affiliation
MSF International, 37 Rue de la Tourelle, 1040 Brussels, Belgium.Issue Date
2001-11
Metadata
Show full item recordAbstract
To ensure access to essential medicines for disadvantaged populations there are at least three conditions to be met: drugs prices must be affordable for poor countries; research and development of drugs for tropical diseases must take place; and there is a need for health exceptions to trade agreements.Publisher
Wiley-BlackwellPubMed ID
11703852Additional Links
http://www.blackwell-synergy.com/loi/tmiLanguage
enISSN
1360-2276Collections
Related articles
- Developing nations and the compulsory license: maximizing access to essential medicines while minimizing investment side effects.
- Authors: Bird RC
- Issue date: 2009 Summer
- An economic justification for open access to essential medicine patents in developing countries.
- Authors: Flynn S, Hollis A, Palmedo M
- Issue date: 2009 Summer
- TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
- Authors: 't Hoen E
- Issue date: 2002 Spring
- Access to essential drugs, human rights and global justice.
- Authors: Shalev C
- Issue date: 2004 Jan
- Basic survival needs and access to medicines--coming to grips with TRIPS: conversion + calculation.
- Authors: Van Puymbroeck RV
- Issue date: 2010 Fall